SCHEMBL4906189

SCHEMBL4906189

COC(=O)c1cc(S(=O)(=O)NCCSc2ccc(-c3ccccc3)nn2)ccc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
ALDH1A1 P00352 9/20 0.44
MAPT P10636 7/20 0.44
TSHR P16473 3/20 0.44
HSD17B10 Q99714 1/20 0.44
HPGD P15428 4/20 0.42
PKM P14618 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
USP2 O75604 1/20 0.41
HTT P42858 1/20 0.41
THRB P10828 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
MAPK1 P28482 1/20 0.40
SLC12A2 P55011 1/20 0.40
SLC12A5 Q9H2X9 1/20 0.40
HCRTR1 O43613 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4894575 0.92 LMNA (0.54) LMNACA1CA2ALDH1A1MAPT
SCHEMBL4902605 0.91 ALDH1A1 (0.41) LMNACA1CA2ALDH1A1MAPT
SCHEMBL4905821 0.84 MAPT (0.43) LMNACA1CA2ALDH1A1MAPT
SCHEMBL4902435 0.81 TSHR (0.49) LMNAALDH1A1MAPTTSHRHSD17B10
SCHEMBL4906202 0.79 RAB9A (0.44) LMNACA1CA2ALDH1A1MAPT
SCHEMBL4906148 0.78 GRK6 (0.48) LMNAALDH1A1MAPTTSHRHPGD
SCHEMBL4902649 0.77 ALDH1A1 (0.54) LMNACA1CA2ALDH1A1MAPT
SCHEMBL4905936 0.76 SMN1; SMN2 (0.54) LMNAALDH1A1MAPTTSHRHSD17B10
SCHEMBL4900537 0.76 ALDH1A1 (0.50) LMNAALDH1A1MAPTTSHRHSD17B10
SCHEMBL4897317 0.74 ALDH1A1 (0.56) LMNACA2ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885CA1 4883/4885CA2 4864/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885CA1 4881/4885CA2 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.